ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer

Yu, Jie; Zhang, QianYun; Wang, MengChuan; Liang, SiJia; Huang, HongYun; Xie, Lang; Cui, ChunHui*; Yu, JinLong*南方医科大学; 中山大学
Bioscience Reports2021-2-3DOI: 10.1042/BSR20203336
18被引12阅读
引用收藏
分享

摘要

Tumor mutation burden (TMB) was a promising marker for immunotherapy. We aimed to investigate the prognostic role of TMB and its relationship with immune cells infiltration in gastric cancer (GC). We analyzed the mutation landscape of all GC cases and TMB of each GC patient was calculated and patients were divided into TMB-high and TMB-low group. Differentially expressed genes (DEGs) between the two groups were identified and pathway analysis was performed. The immune cells infiltration in each GC patient was evaluated and Kaplan-Meier analysis was performed to investigate the prognostic role of immune cells infiltration. At last, hub immune genes were identified and a TMB prognostic risk score (TMBPRS) was constructed to predict the survival outcome of GC patients. The relationships between mutants of hub immune genes and immune infiltration level in GC was investigated. We found higher TMB was correlated with better survival outcome and female patients, patients with T1-2 and N0 had higher TMB score. Altogether 816 DEGs were harvested and pathway analysis demonstrated that patients in TMB-high group were associated with neuroactive ligand-receptor interaction, cAMP signaling pathway, calcium signaling pathway. The infiltration of activated CD4(+) memory T cells, follicular helper T cells, resting NK cells, M0 and M1 macrophages and neutrophils in TMB-high group were higher compared than that in TMB-low group and high macrophage infiltration was correlated with inferior survival outcome of GC patients. Lastly, the TMBPRS was constructed and GC patients with high TMBPRS had poor prognosis.

学科与关键词

关键词
BREAST-CANCERPD-1BIOMARKERIMMUNOTHERAPYCHEMOTHERAPYNIVOLUMABBLOCKADEINVASION
相关
加载中…
  • The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
    Cui, Shengjin; Feng, Jingying; Tang, Xi; Lou, Shuang; Guo, Weiquan; Xiao, Xiaowei; Li, Shuping; Chen, Xue; Huan, Yu; Zhou, Yiwen*; Xiao, Lijia*EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28(1): 90.被引 1
  • Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
    Chen, Yan*; Sun, Zepang; Wan, Li; Chen, Hongzhuan; Xi, Tieju; Jiang, Yuming*Frontiers in Immunology, 2022, 13: 890922.被引 4
  • Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma
    Luo, Yong; Chen, Qingbiao*; Lin, Jingbo*Mathematical Biosciences and Engineering, 2022, 19(7): 7055-7075.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioscience Reports
发表日期
2021-02-03
卷期
第 41 卷, 第 2 期
页码
BSR20203336
DOI
10.1042/BSR20203336
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [8197032867]; Natural Science Foundation of Guangdong Province, China [2017A030313488]; Scientific and Technological Program of Guangzhou City [201707010104]

作者

  • Y

    Yu, Jie (第一作者)

    southern med univ

  • Z

    Zhang, QianYun

    guangzhou women & childrens med ctr

查看全部 8 位作者收起作者
  • W

    Wang, MengChuan

    southern med univ

  • L

    Liang, SiJia

    sun yat sen univ

  • H

    Huang, HongYun

    southern med univ

  • X

    Xie, Lang

    southern med univ

  • C

    Cui, ChunHui (通讯)

    southern med univ

  • Y

    Yu, JinLong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417